Frequency of selected HLA-DRB1 haplotypes in the NI-CINA patients
Haplotype . | Patients (%)‡ (n = 56) . | Healthy controls (%) (n = 39) . | χ2-value† . | Pvalue . |
---|---|---|---|---|
HLA-DRB1*0101 | 4 (7.14) | 2 (5.13) | 0.9748 | ns |
HLA-DRB1*0301 | 3 (5.36) | 1 (2.56) | 0.8827 | ns |
HLA-DRB1*0701 | 12 (21.43) | 6 (15.38) | 0.6359 | ns |
HLA-DRB1*1001 | 2 (3.57) | 3 (7.69) | 0.6761 | ns |
HLA-DRB1*1101 | 10 (17.86) | 12 (30.77) | 0.2223 | ns |
HLA-DRB1*1104 | 21 (37.5) | 15 (38.46) | 0.9045 | ns |
HLA-DRB1*1201 | 2 (3.57) | 2 (5.13) | 0.8827 | ns |
HLA-DRB1*1301 | 3 (5.36) | 5 (12.82) | 0.3612 | ns |
HLA-DRB1*1302 | 12 (21.43) | 1 (2.56) | 5.4210 | P = .0199 |
HLA-DRB1*1401 | 5 (8.93) | 6 (15.38) | 0.5212 | ns |
HLA-DRB1*1501 | 3 (5.36) | 4 (10.26) | 0.6171 | ns |
HLA-DRB1*1502 | 4 (7.14) | 3 (7.69) | 0.7655 | ns |
HLA-DRB1*1601 | 10 (17.86) | 3 (7.69) | 0.2650 | ns |
Haplotype . | Patients (%)‡ (n = 56) . | Healthy controls (%) (n = 39) . | χ2-value† . | Pvalue . |
---|---|---|---|---|
HLA-DRB1*0101 | 4 (7.14) | 2 (5.13) | 0.9748 | ns |
HLA-DRB1*0301 | 3 (5.36) | 1 (2.56) | 0.8827 | ns |
HLA-DRB1*0701 | 12 (21.43) | 6 (15.38) | 0.6359 | ns |
HLA-DRB1*1001 | 2 (3.57) | 3 (7.69) | 0.6761 | ns |
HLA-DRB1*1101 | 10 (17.86) | 12 (30.77) | 0.2223 | ns |
HLA-DRB1*1104 | 21 (37.5) | 15 (38.46) | 0.9045 | ns |
HLA-DRB1*1201 | 2 (3.57) | 2 (5.13) | 0.8827 | ns |
HLA-DRB1*1301 | 3 (5.36) | 5 (12.82) | 0.3612 | ns |
HLA-DRB1*1302 | 12 (21.43) | 1 (2.56) | 5.4210 | P = .0199 |
HLA-DRB1*1401 | 5 (8.93) | 6 (15.38) | 0.5212 | ns |
HLA-DRB1*1501 | 3 (5.36) | 4 (10.26) | 0.6171 | ns |
HLA-DRB1*1502 | 4 (7.14) | 3 (7.69) | 0.7655 | ns |
HLA-DRB1*1601 | 10 (17.86) | 3 (7.69) | 0.2650 | ns |